Literature DB >> 25720395

Postmortem Alzheimer's Disease Hippocampi Show Oxidative Phosphorylation Gene Expression Opposite that of Isolated Pyramidal Neurons.

Ann C Rice1, Amy C Ladd2, James P Bennett3.   

Abstract

Causes of initiation and progression of sporadic Alzheimer's disease (sAD) are likely multiple and include impairment of mitochondrial bioenergetics. We analyzed RNA expression levels of multiple mitochondrial oxidative phosphorylation (OXPHOS) and biogenesis (mitobiogenesis) genes in unfixed hippocampal (WH) frozen sections (10 sAD; 9 CTL) and laser-captured hippocampal pyramidal neurons (PyNs, ~1000 neurons from each case) from 8 sAD and 7 CTL cases. Nuclear-encoded OXPHOS genes in WH were significantly increased in sAD, whereas in isolated sAD PyNs, these same genes were significantly decreased. Mitochondrial DNA-encoded genes were increased in sAD PyNs but showed a non-significant downward trend in sAD WH. Relationships among WH and PyN gene expression levels in sAD distributed in a different population compared to CTL. Principal component analysis (PCA) revealed clustering of CTL but widespread heterogeneity of sAD samples. In sAD, mitochondrial bioenergetics at the gene expression level are depressed in vulnerable PyNs. PCA revealed that CTL samples clustered together, whereas sAD samples varied widely. From the perspective of OXPHOS bioenergetics, sAD is a heterogeneous syndrome and not likely due to a single abnormality. Increased stimulation of nuclear-encoded OXPHOS gene expression in PyNs is a rational therapeutic approach for most but not all cases of sAD.

Entities:  

Keywords:  Laser capture microdissection; mitochondria; mitochondrial biogenesis; quantitative PCR; relative gene expression

Mesh:

Year:  2015        PMID: 25720395     DOI: 10.3233/JAD-142937

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Diego Mastroeni; Omar M Khdour; Elaine Delvaux; Jennifer Nolz; Gary Olsen; Nicole Berchtold; Carl Cotman; Sidney M Hecht; Paul D Coleman
Journal:  Alzheimers Dement       Date:  2016-10-25       Impact factor: 21.566

2.  Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Shaoli Che; Irina Elarova; Yinghua Chen; Freddy Jeanneteau; Thorsten M Kranz; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Hippocampus       Date:  2017-09-27       Impact factor: 3.899

3.  PGC-1α regulates the cell cycle through ATP and ROS in CH1 cells.

Authors:  Xu-feng Fu; Kun Yao; Xing Du; Yan Li; Xiu-yu Yang; Min Yu; Mei-zhang Li; Qing-hua Cui
Journal:  J Zhejiang Univ Sci B       Date:  2016-02       Impact factor: 3.066

Review 4.  Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.

Authors:  Wenzhang Wang; Fanpeng Zhao; Xiaopin Ma; George Perry; Xiongwei Zhu
Journal:  Mol Neurodegener       Date:  2020-05-29       Impact factor: 14.195

5.  Brain pyrimidine nucleotide synthesis and Alzheimer disease.

Authors:  Alba Pesini; Eldris Iglesias; M Pilar Bayona-Bafaluy; Nuria Garrido-Pérez; Patricia Meade; Paula Gaudó; Irene Jiménez-Salvador; Pol Andrés-Benito; Julio Montoya; Isidro Ferrer; Pedro Pesini; Eduardo Ruiz-Pesini
Journal:  Aging (Albany NY)       Date:  2019-09-27       Impact factor: 5.682

6.  Effects of Magnesium Orotate, Benfotiamine and a Combination of Vitamins on Mitochondrial and Cholinergic Function in the TgF344-AD Rat Model of Alzheimer's Disease.

Authors:  Christian Viel; Adrian T Brandtner; Alexander Weißhaar; Alina Lehto; Marius Fuchs; Jochen Klein
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.